QHM-2025-8891 Sri Arya Healthcare Ltd

The public procurement process for contract QHM-2025-8891, overseen by NHS North East and North Cumbria Integrated Care Board, focuses on pharmacy services. This specific procurement falls under the healthcare industry category, governed by the Health Care Services (Provider Selection Regime) Regulations 2023, and is located in the UKC region. Notably, this procedure employed a direct award under the regulatory framework without a prior competitive call for participation.

An initial intention to award notice was released on 25th September 2025, marking the commencement of a standstill period, which lasted until 8th October 2025. The contract commenced on 1st April 2025 and is set to conclude by 31st March 2026. The purchasing strategy allowed the existing provider to continue services based on satisfaction of the established contract criteria.

This procurement presents significant opportunities for businesses within the pharmacy services domain, particularly those with capabilities similar to those offered by the incumbent provider, Sri Arya Healthcare Ltd. Companies that can demonstrate compliance with stringent industry standards, effectively manage activity-based contracts, and navigate the regulatory framework of the health sector in the UK will find themselves well-positioned to engage in such opportunities. Due to the specialised nature of the procurement process, large-scale healthcare companies capable of delivering reliable and quality services on a national level would be best suited to meet the demands of this procurement. Engaging in such contracts provides a platform for sustainable growth and expansion within the competitive and regulatory healthcare service market.